Antigen Presentation to Th1 but Not Th2 Cells by Macrophages Results in Nitric Oxide Production and Inhibition of T Cell Proliferation: Interferon-γ Is Essential but Insufficient

2000 ◽  
Vol 206 (2) ◽  
pp. 125-135 ◽  
Author(s):  
Roel C. van der Veen ◽  
Therese A. Dietlin ◽  
Ligaya Pen ◽  
J.Dixon Gray ◽  
Florence M. Hofman
2005 ◽  
Vol 175 (3) ◽  
pp. 1586-1592 ◽  
Author(s):  
Tomohide Yamazaki ◽  
Hisaya Akiba ◽  
Akemi Koyanagi ◽  
Miyuki Azuma ◽  
Hideo Yagita ◽  
...  

1998 ◽  
Vol 184 (2) ◽  
pp. 105-111 ◽  
Author(s):  
Stanislava Stošić-Grujičić ◽  
Vladimir Trajković ◽  
Vladimir Badovinac ◽  
Marija Mostarica Stojković

2017 ◽  
Vol 140 (4) ◽  
pp. 605-612 ◽  
Author(s):  
Takayuki Nagano ◽  
Ryo Nishiyama ◽  
Ayaka Sanada ◽  
Yukiko Mutaguchi ◽  
Anna Ioku ◽  
...  

Antioxidants ◽  
2021 ◽  
Vol 10 (7) ◽  
pp. 1120
Author(s):  
Dae Woon Choi ◽  
Sun Young Jung ◽  
Gun-Dong Kim ◽  
So-Young Lee ◽  
Hee Soon Shin

Allergic diseases, including atopic dermatitis (AD), induce type 2 helper T (Th2) cell-dominant immune responses. Miquelianin (quercetin 3-O-glucuronide, MQL) is an active compound in Rosae multiflorae fructus extract with anti-allergic properties. Here, we investigate the anti-allergic effects of MQL in an ovalbumin (OVA)-induced Th2-dominant mouse model and the associated mechanisms. Oral MQL suppressed cytokine and IL-2 production and proliferation of Th2 cells and upregulated heme oxygenase-1 (HO-1) in splenocytes. Ex vivo MQL suppressed Th1- and Th2-related immune responses by inhibiting CD4+ T cell proliferation, and upregulated HO-1 in CD4+ T cells by activating C-Raf–ERK1/2–Nrf2 pathway via induction of reactive oxygen species generation. In a trimellitic anhydride-induced AD-like mouse model, both topical and oral MQL ameliorated AD symptoms by suppressing Th2 immune responses. Our results suggest that MQL is a potential therapeutic agent for CD4+ T cell-mediated diseases, including allergic diseases.


Blood ◽  
2006 ◽  
Vol 109 (1) ◽  
pp. 228-234 ◽  
Author(s):  
Kazuya Sato ◽  
Katsutoshi Ozaki ◽  
Iekuni Oh ◽  
Akiko Meguro ◽  
Keiko Hatanaka ◽  
...  

Abstract The molecular mechanisms by which mesenchymal stem cells (MSCs) suppress T-cell proliferation are poorly understood, and whether a soluble factor plays a major role remains controversial. Here we demonstrate that the T-cell–receptor complex is not a target for the suppression, suggesting that downstream signals mediate the suppression. We found that Stat5 phosphorylation in T cells is suppressed in the presence of MSCs and that nitric oxide (NO) is involved in the suppression of Stat5 phosphorylation and T-cell proliferation. The induction of inducible NO synthase (NOS) was readily detected in MSCs but not T cells, and a specific inhibitor of NOS reversed the suppression of Stat5 phosphorylation and T-cell proliferation. This production of NO in the presence of MSCs was mediated by CD4 or CD8 T cells but not by CD19 B cells. Furthermore, inhibitors of prostaglandin synthase or NOS restored the proliferation of T cells, whereas an inhibitor of indoleamine 2,3-dioxygenase and a transforming growth factor–β–neutralizing antibody had no effect. Finally, MSCs from inducible NOS−/− mice had a reduced ability to suppress T-cell proliferation. Taken together, these results suggest that NO produced by MSCs is one of the major mediators of T-cell suppression by MSCs.


Sign in / Sign up

Export Citation Format

Share Document